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ABSTRACT
Background and aims A general dysbiosis of the
intestinal microbiota has been established in patients
with Crohn’s disease (CD), but a systematic
characterisation of this dysbiosis is lacking. Therefore the
composition of the predominant faecal microbiota of
patients with CD was studied in comparison with the
predominant composition in unaffected controls.
Whether dysbiosis is present in relatives of patients CD
was also examined.
Methods Focusing on families with at least three
members affected with CD, faecal samples of 68
patients with CD, 84 of their unaffected relatives and 55
matched controls were subjected to community
fingerprinting of the predominant microbiota using
denaturing gradient gel electrophoresis (DGGE). To
analyse the DGGE profiles, BioNumerics software and
non-parametric statistical analyses (SPSS V.17.0) were
used. Observed differences in the predominant
microbiota were subsequently confirmed and quantified
with real-time PCR.
Results Five bacterial species characterised dysbiosis in
CD, namely a decrease in Dialister invisus (p¼0.04), an
uncharacterised species of Clostridium cluster XIVa
(p¼0.03), Faecalibacterium prausnitzii (p<1.33105)
and Bifidobacterium adolescentis (p¼5.43106), and an
increase in Ruminococcus gnavus (p¼2.13107).
Unaffected relatives of patients with CD had less
Collinsella aerofaciens (p¼0.004) and a member of the
Escherichia colieShigella group (p¼0.01) and more
Ruminococcus torques (p¼0.02) in their predominant
microbiota as compared with healthy subjects.
Conclusion Unaffected relatives of patients with CD
have a different composition of their microbiota
compared with healthy controls. This dysbiosis is not
characterised by lack of butyrate producing-bacteria as
observed in CD but suggests a role for microorganisms
with mucin degradation capacity.
BACKGROUND AND AIMS
The role of the commensal microbiota in the
initiation and perpetuation of the intestinal
inﬂammation in Crohn’s disease (CD) is well
established.1e5 A general dysbiosis in patients with
CD has been described with both culture-depen-
dent and culture-independent techniques,6e8 but
whether the observed dysbiosis is either cause or
consequence of the disease remains unclear.4
Several studies have reported an overall lower
biodiversity in patients with CD. At the group-
speciﬁc level, lower numbers of members of the
Firmicutes phylum and of the Clostridium cluster
IV combined with higher numbers of Bacteroides
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Significance of this study
What is already known about this subject?
< The role of bacteria in the pathogenesis of Crohn’s
disease (CD) is well established (clinical presenta-
tion and lesions of the disease are localised in areas
of highest bacterial exposure, clinical response of
patients to diversionof the faecal streamand relapse
on restoration or exposure to faecalmaterial, clinical
response to antibacterial treatment, absence of
disease in germ-free animal models, susceptibility
genes for CD are involved in recognition of and
defence against microorganisms).
< In patients, a general dysbiosis has been
described with at the group-specific level
lower numbers of members of the Firmicutes
phylum and of the Clostridium cluster IV
combined with higher numbers of Bacteroides.
< Until now, the species-specific finding that has
been most convincingly replicated is the lower
presenceof Faecalibacteriumprausnitzii in patients
with CD both in faecal samples and in biopsies.
What are the new findings?
< We now provide the first detailed description of
this dysbiosis in patients with CD.
< Based on differences in the predominant faecal
microbiota in the largest cohort studied so far,
we were able to describe a dysbiosis signature
associated with CD, characterised by five
bacterial species, namely Dialister invisus, an
uncharacterised species of Clostridium cluster
XIVa, Faecalibacterium prausnitzii, Bifidobacte-
rium adolescentis and Ruminococcus gnavus.
< This dysbiosis signature was markedly charac-
teristic for the disease as it was not observed in
unaffected relatives despite a common genetic
background and shared nutritional habits.
< We demonstrate further for the first time that
unaffected relatives of patients with CD also
have a different composition of their microbiota
compared with healthy controls.
How might it impact on clinical practice in the
foreseeable future?
< This first detailed description of CD-associated
dysbiosis will break new ground in unravelling
the role of bacteria in CD.
< Furthermore, uncovering this subclinical
dysbiosis in unaffected subjects at risk
allowed us to hypothesise that enhanced
mucin degradation capacity of the intestinal
microbiota might be an intermediate step
towards CD and disease-associated dysbiosis.
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have been reported.9e11 In several studies a proportional abun-
dance of mucosa-associated Escherichia coli in CD has been
described, but these ﬁndings are self-evidently limited to
mucosal samples.12e14 Until now, the species-speciﬁc ﬁnding
that has been most convincingly replicated is the lower presence
of Faecalibacterium prausnitzii in patients with CD both in faecal
samples and in biopsies.7 15e17 Moreover, the ability to produce
butyrate and the anti-inﬂammatory properties of this species
provide a coherent biological explanation for its lower presence
in patients with CD.15 A more extended and detailed description
of the observed dysbiosis in CD is, however, still lacking.
The abnormal response to commensal intestinal bacteria in
CD might be driven by the genetic background of the host, as
many of the identiﬁed susceptibility genes for CD play a role in
bacterial sensing. The ﬁrst gene identiﬁed in CD, NOD2/
CARD15, belongs to the family of pattern recognition receptors
(PRRs) which are part of the human innate immunity.18 19 PRRs
recognise speciﬁc bacterial sequences and are responsible for the
defence against those organisms. Toll-like receptors (TLRs) were
the ﬁrst class of cellular PRRs identiﬁed and are the best known
PRRs.20 An association between the functional Asp299Gly
polymorphism in TLR-4 and inﬂammatory bowel disease (IBD)
has been demonstrated.21 Also the importance of autophagy
in CD became clear as a result of genome-wide association
scanning which has identiﬁed the autophagy-related 16-like
1 (ATG16L1) gene and immune-related guanosine triphosphatase
(IRGM).22 23 To test the impact of the host genotype on the
intestinal microbiota, comparisons were made between faecal
samples from subjects with differing genetic relatedness, varying
from unrelated persons to monozygotic twins.24e26 A higher
similarity between samples was found with a higher degree of
genetic relatedness. These studies thus indicated a signiﬁcant
impact of the host genotype on the bacterial composition of
faecal samples but did not ﬁnd a clear environmental effect. The
interaction of host genotype with the composition of the
intestinal microbiota is still poorly understood, but CD twin
studies provide evidence that the bacterial composition is more
inﬂuenced by disease status than by the genetic background of
the host.7 17
Although supported by little evidence, the composition of the
intestinal microbiota is also likely to be inﬂuenced by other
factors such as dietary habits and the environment. Both genetic
and environmental factors are shared within families, and ﬁrst-
degree relatives of patients with CD are at much higher risk of
developing CD as compared with the general population.27 In
this regard, we previously reported a 57-fold increase in the
incidence of IBD within multiply affected families.28 29
The aim of the current study was to investigate to what
extent the predominant faecal microbiota of patients with CD
has unique characteristics that discriminates them from healthy
subjects with and/or without a shared familial background.
Furthermore, we hypothesised that intestinal dysbiosis might be
a precursor for CD and, as a consequence, that relatives, or
a subgroup of them, also might have asymptomatic intestinal
dysbiosis.
METHODS
Subjects and study design
Microbial DNA from stool samples of patients with CD was
compared with that of their unaffected relatives and healthy
subjects from families of comparable generation, gender distri-
bution and family composition for whom the recruitment and
matching criteria were previously described.29 Subjects taking
antibiotics within 4 weeks before the faecal sampling, following
a speciﬁc diet, using probiotics or suffering from irritable bowel
syndrome (IBS) were excluded from the analyses. A total of 68
patients with CD from 25 families, 84 of their unaffected rela-
tives and 55 healthy subjects from 10 control families were
studied (table 1). Four families had only one member affected
with CD; 21 families had at least three affected members. Of the
84 unaffected relatives in our cohort, 80 were ﬁrst-degree (thus
primary) relatives of patients with CD (48 siblings, 31 parents of
patients with CD and one unaffected subject that had both
affected siblings and offspring). The four that did not have ﬁrst-
degree relatives with CD lived in a close relationship with four
patients with CD.
We used large families which resulted overall in balanced
numbers of unaffected relatives and patients per family. The
median number of unaffected relatives used per family was 3
(IQR 1e4). For patients, the median number per family was also
3 (IQR 2e3). The median ratio of unaffected relatives to
patients per family was 1 (IQR 0.67e1.75). All patients were in
clinical remission at the time of sampling. The patient charac-
teristics at the time of sampling are summarised in table 2.
The Ethics Committee of the University of Leuven (Belgium)
approved the study, and all participants gave informed consent.
Faecal samples were collected from each subject and upon
collection they were immediately frozen at 808C and stored for
DNA extraction.
Denaturing gradient gel electrophoresis (DGGE) profiling
To identify potential microbial characteristics of CD, an objec-
tive comparison by means of a community ﬁngerprinting
approach based on DGGE analysis of ribosomal PCR amplicons
was performed.30 Therefore, total bacterial DNA was extracted
from the faecal samples using the method of Pitcher and
colleagues with slight modiﬁcations.31 Next, community PCR
was conducted using universal primers F357+GC clamp and
R518 targeting the hypervariable V3 region of the 16S rRNA
gene. The resulting 16S rRNA gene amplicons were analysed
with DGGE using a 35e70% gradient as previously described,31
resulting in proﬁles of the predominant faecal microbiota per
subject. On each DGGE gel, a standard reference consisting of an
amplicon mix of 12 different bacterial species was included in
the middle and at both outer ends for digital gel normalisation
and to allow comparison between gels.
Digital processing of DGGE profiles
DGGE proﬁles were digitally processed with BioNumerics soft-
ware version 4.6 (Applied Maths, St-Martens-Latem, Belgium) in
a multistep procedure following the manufacturer ’s instruc-
tions. After normalisation of the gels, individual bands in each
sample lane were marked using the auto search bands option,
followed by manual correction if necessary. All proﬁles were
compared using the band matching tool and uncertain bands
were included in the position tolerance settings. Allocation of
bands to so-called band-classes was performed automatically
Table 1 Faecal samples used for analysis represented per group
Patients
with CD
n[68
Unaffected
relatives
n[84
Control
subjects
n[ 55
Age (years)* 45 (25e76) 52 (14e86) 50 (28e78)
Gender (% females) 59% 50% 55%
Age at diagnosis (years)* 28 (12e55) NA NA
Disease duration (years)* 17 (2e57) NA NA
*The mean is given, with the minimum and maximum in parentheses.
CD, Crohn’s disease; NA, not applicable.
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and again checked manually. Essentially, band-classes were
arbitrarily generated in a collective analysis of all proﬁles by
tracing common bands across different sample proﬁles. This
allowed every band in a proﬁle to be assigned to its nearest band-
class. A maximum error of 0.5% deviation was applied, which
means that a band was only allocated if it was located at
a distance of <0.5% of the total length of the proﬁle from the
closest band-class. The designation of the band-classes was based
on their position on the proﬁle compared with the standard
reference. The intensity of a given band-class was expressed
with respect to the other band-classes on the same proﬁle.
Comparative analyses of the DGGE profiles
The quantitative information derived from relative band inten-
sities per subject and per band-class was exported as a data
matrix. Bacterial groups present in quantities under the detec-
tion limit were denoted as zero. Non-parametric tests were
applied to compare differences in the complex proﬁles across
groups (table 1). Therefore ManneWhitney U tests on the
intensity per band-class were used to compare the groups in
SPSS V.17.0. To correct for multiple testing, all p values were
multiplied by the number of band-classes obtained (n¼75). Only
two-tailed p values <0.05 after correction were considered
signiﬁcant.
DGGE band extraction and sequencing
DGGE bands that differed signiﬁcantly between groups
according to the statistical analysis were puriﬁed from the
complex faecal samples, before they were sequenced, by excision
from the gel. The DNAwas eluted from the gel slice into 15 ml of
TE buffer by heating the mixture of buffer and gel for 10 min at
658C. The resulting DNA solution was then ampliﬁed again
using the universal V3 16S rRNA primers F357+GC clamp and
R518. Puriﬁcation of the bands was facilitated by using DGGE
gel expansion where the amplicons were checked by DGGE with
an adjusted gradient32 and again excised at least three times
until a single band was obtained. The purpose of repeating
DGGE until one single band is obtained is only to purify the
PCR product before it can be sequenced. In a ﬁnal DGGE round,
puriﬁed amplicons were analysed together with the original
sample proﬁles from which they were excised to check visually
whether the correct bands were puriﬁed.
When puriﬁed bands matched with the targeted bands in the
sample proﬁles, amplicons were selected for sequencing using an
ABI Prism 3130 Genetic Analyzer (Applied Biosystems, Foster
City, California, USA). Sequences were read from both direc-
tions with primers F357 (without clamp) and R518, respectively.
The sequence was assembled with BioNumerics software.
Homology searches of the GenBank DNA database were
performed with BLAST search. Based on the BLAST results,
reference sequences of phylogenetic neighbour species (up to
90% similarity) were included for clustering analysis using
multiple sequence alignment and the average linking method to
conﬁrm allocation of the puriﬁed band sequences to the most
probable species.
Real-time PCR
Bacterial species that differed signiﬁcantly in the comparative
DGGE band-class analyses were quantiﬁed with the Applied
Biosystems 7500 Fast Real-Time PCR (RT-PCR) System in the
fast 7500 mode. Primers (Primer express 3.0 software) that
spanned a target region in the V3 region of the 16S rRNA gene
species of interest were selected (Supplementary table 1). The
RT-PCR was carried out in a 20 ml total reaction mixture using
4 ml of DNA. Calibration curves were constructed using dilu-
tions of genomic DNA from a control strain (Supplementary
table 1) for which the number of bacteria was determined by
plate counting. The quantitative results of the RT-PCR analyses
were based on measurements in triplicate with a maximum
variation <0.5 Ct. Amounts of bacterial species were expressed
as log10 values per gram wet weight of faeces.
RESULTS
Differences in five bacterial species characterise predominant
dysbiosis in CD
In the 207 PCR-DGGE proﬁles analysed in this study, 75 band-
classes were identiﬁed. We ﬁrst compared patients with CD
versus all unaffected controls (unaffected relatives and unrelated
controls taken together) in search of disease-associated charac-
teristics of the predominant faecal microbiota. After Bonferroni
correction for the 75 band-classes, signiﬁcant differences were
observed between the patients with CD and unaffected subjects
for seven band-classes. To assign these seven band-classes to
a bacterial species or phylotype, DNA was puriﬁed per band-
class from at least ﬁve different samples originating from
different patients, unaffected relatives and controls. Puriﬁed
amplicons were analysed together with the original sample
proﬁles from which they were excised, to check visually whether
the correct bands were puriﬁed. After puriﬁcation, band-class
3.72 appeared to be composed of different bands. We thus
concluded that this band-class did not represent a single bacterial
species and therefore it was not studied further. All other puri-
ﬁed bands of the remaining six band-classes matched with the
targeted bands in the sample proﬁles, and these amplicons were
sequenced. Within each band-class all generated sequences
(length 135 bp, representing 8.7e9.5% of the 16S rRNA gene)
were identical. Band-classes were tentatively assigned to
a bacterial species or phylotype based on the highest (98e100%)
sequence similarity match to GenBank sequences obtained by
BLAST analysis (Supplementary table 2). These species assign-
ments were subsequently conﬁrmed by clustering analysis
with reference sequences of the closest phylogenetic neighbours.
Table 2 Patient characteristics at the time of sampling
No. of patients with CD
Location*
Ileum (L1) 27
Colon (L2) 6
Ileocolon (L3) 31
Behaviour*
Non-stricturing, non-penetrating (B1) 25
Structuring (B2) 22
Penetrating (B3) 13
Previous surgery*
Yes 40
No 20
Medical treatment at time of sampling*
Immunosuppressants 10
Steroids 3
NSAIDs 3
Sulfasazines 12
Mesalazines 8
*Maximal disease extent at the time of sampling was available in 64/68 patients; disease
behaviour at last follow-up before the time of sampling was available in 60/68 patients;
previous surgery at the time of sampling was available in 60/68 patients (type of surgery:
5/40 unknown, 1/40 gastric Roux-en-Y anastomosis, 16/40 partial ileal and partial colonic
resection, 2/40 (sub)total colectomies, 11/40 hemicolectomies, 5/40 partial ileal resection);
medical treatment at the time of sampling was available in 57/68 patients.
CD, Crohn’s disease; NSAIDs, non-steroidal anti-inflammatory drugs.
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In this way, band-classes 9.68 and 11.51 were both assigned to
F prausnitzii, band-class 11.00 was assigned to Ruminococcus
gnavus, band-class 14.60 was assigned to Dialister invisus and
band-class 16.24 was assigned to Biﬁdobacterium adolescentis.
Based on its phylogenetic position revealed by clustering anal-
ysis, band-class 10.79 could be assigned to an uncharacterised
species of Clostridium cluster XIVa.
The disproportion of these ﬁve bacterial species that charac-
terise the observed differences between the patients with CD
and unaffected subjects are represented per band-class in ﬁgure 1
and in ﬁgure 2 the occurrence in the DGGE proﬁles is expressed
in terms of a percentage.
We also analysed the predominant faecal proﬁles of the
patients with CD according to the clinical phenotypes described
in table 2. However, none of the dysbalanced bacterial species
was associated with a speciﬁc clinical phenotype. Only when
comparing predominant microbial proﬁles of the subgroup of
patients with CD that underwent an ileocolonic resection
(n¼16) prior to sampling with the subgroup of patients that
never had an intestinal operation (n¼20) was a signiﬁcant
quantitative difference in F prausnitzii revealed (corrected
p value¼0.002) with even less F prausnitzii in patients with CD
after ileocolonic resection.
Influence of the genetic and environmental background
on the predominant microbiota
Because the composition of the intestinal microbiota is likely to
be inﬂuenced by many factors, and both genetic and environ-
mental factors are shared within families, we next compared
patients with their unaffected relatives. No differences could be
found between patients or unaffected relatives according to the
number of affected relatives. In other words, we did not ﬁnd
differences between single incidence families and multiplex
families. Therefore, we combined both groups.
However, when comparing the patient group only with their
unaffected relatives, all six band-classes except band-class 10.79
(unknown species of Clostridium cluster XIVa) remained signiﬁ-
cantly different between both groups and no additional
discriminative band-classes were identiﬁed.
To evaluate the effect of the genetic and environmental
background on the observed differences in patients with CD, we
then compared the patient group with unrelated control
subjects only, to allow a larger potential impact of genetic and
environmental factors. All except band-classes 11.51 (F praus-
nitzii) and 14.60 (D invisus) remained signiﬁcantly different
between both unrelated groups.
Subclinical dysbiosis in asymptomatic relatives of patients
with CD
Proﬁles of unaffected relatives were compared with those of
unrelated control subjects in search of asymptomatic intestinal
dysbiosis in relatives. Three band-classes differed signiﬁcantly
between both unaffected groupsdthat is, band-classes 8.55,
11.35 and 16.89 (table 3). Interestingly, the differences observed
between unaffected relatives and unrelated control subjects were
also observed in patients with CD compared with unrelated
controls, but to a lesser extent, and therefore were not signiﬁ-
cantly different. For the predominant occurrence of the bacterial
species that (statistically) differed between unaffected relatives
of patients with CD and healthy controls, the values of the
unaffected relatives are at one extreme, those of the healthy
controls at the other extreme, and those of patients with CD are
in between. The prevalence of patients with CD for these band-
classes was thus situated in between the prevalence of unrelated
Figure 1 Examples of denaturing gradient gel
electrophoresis (DGGE) profiles. The letters next to
the picture correspond to the letters in the right
table per bandclass. Each of the six lanes shown
on the left represents a DGGE profile visualising the
predominant faecal microbiota of one subject.
the left picture. 
Figure 2 Denaturing gradient gel electrophoresis (DGGE) band-classes
that differed in the predominant faecal microbiota of patients with
Crohn’s disease (CD), their unaffected relatives and control subjects,
expressed as a percentage of subjects with the respective band in their
predominant profile per band-class and per group. Inclined, the
corresponding bacterial species are added.
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controls and that of unaffected relatives (ﬁgure 2). After puriﬁ-
cation and sequencing, BLAST analysis in GenBank revealed
100% similarity of band-class 8.55 to Coprococcus comes, Clos-
tridium nexile and Ruminococcus torques. Band-class 11.35 showed
100% sequence similarity to members of the E colieShigella
group whereas band-class 16.89 was identiﬁed as Collinsella
aerofaciens. Subsequent clustering analysis conﬁrmed that band-
class 11.35 can be assigned to a member of the E colieShigella
group, and that band-class 16.89 could be assigned to C aero-
faciens. Clustering analysis indicated that R torques rather than
C comes or C nexile was phylogenetically the closest species
corresponding to band-class 8.55.
To check for family-associated effects on band-class distribu-
tion, we analysed the band-classes using family as the grouping
variable and did not ﬁnd signiﬁcant differences for the band-
classes that we identiﬁed as characterising CD-associated
dysbiosis or for those characterising subclinical dysbiosis in
unaffected relatives.
Quantitative validation of disease-associated differences in
predominant microbiota with RT-PCR
CD-associated predominant dysbiosis was consistently deter-
mined by differences in band-classes assigned to F prausnitzii,
R gnavus and B adolescentis in the different comparisons made.
Therefore, these three species were quantiﬁed with RT-PCR. As
the quantitative data obtained were not normally distributed
(KolmogoroveSmirnova test statistics: p values <0.023), we
performed a non-parametric ManneWhitney U test to compare
the groups. The median number of F prausnitzii was 9.58 log10/g
in patients with CD (IQR 7.40e11.07 log10/g) and 11.45
log10/g in unaffected controls (IQR 10.92e11.90 log10/g)
(p¼2.6131011) (ﬁgure 3A). The median number of R gnavus
was 8.44 log10/g in patients (IQR 7.17e9.51 log10/g) and
7.51 log10/g in unaffected controls (IQR 6.31e8.81 log10/g)
(p¼6.003103) (ﬁgure 3B). The median number of B adolescentis
was 5.00 log10/g in patients (IQR 4.31e6.65 log10/g) and
8.34 log10/g in unaffected controls (IQR 5.21e9.14 log10/g)
(p¼1.5931010) (ﬁgure 3C). The differences in the quantitative
data per group reﬂect the disproportions identiﬁed in the
predominant microbiota and provide a quantitative validation of
the DGGE band-class analysis results.
DISCUSSION
In this study we identiﬁed ﬁve disproportionate bacterial species
that characterise dysbiosis in the predominant faecal microbiota
of a large cohort of patients with CD. This dysbiosis signature
we found in patients with CD was markedly characteristic for
the disease as it was not observed in unaffected relatives despite
a common genetic background and shared nutritional habits.
The butyrate producer F prausnitzii occurred signiﬁcantly less in
the predominant microbial proﬁles of patients with CD. In
agreement with recent ﬁndings of Sokol and co-workers,
signiﬁcantly lower numbers of this species were also detected by
RT-PCR in patients with CD as compared with unaffected
subjects.33 In contrast, we found that R gnavus appeared more in
the predominant faecal microbiota of patients with CD. The
higher occurrence of R gnavus in patients with CD has been
described previously in mucosal samples of patients with ileal
disease.34 We were also able to demonstrate the higher preva-
lence of this species in faecal samples of patients with CD, both
in the predominant proﬁles and by quantitative PCR. In vitro,
R gnavus expresses very high b-glucuronidase activity.35
b-Glucuronidase activity can induce the formation of toxic
compounds in the colon which might cause or perpetuate local
inﬂammation. A third bacterial species that clearly differed
between patients with CD and unaffected controls was B
adolescentis. The lower occurrence of biﬁdobacteria in general in
patients with CD has been described earlier,36 but we have now
speciﬁcally demonstrated for the ﬁrst time the lower prevalence
of B adolescentis both qualitatively and quantitatively.
To our knowledge, the lower occurrence of D invisus in
patients with CD has never been reported before. Interestingly,
this species was ﬁrst isolated from dental root infections,37 but
has also been detected as part of the normal intestinal micro-
biota.38 The sequence of band-class 10.79 was assigned to an
uncharacterised species of Clostridium cluster XIVa that was
under-represented in the predominant microbial proﬁles of
patients with CD. This sequence showed 100% similarity with
the 16S rRNA sequence of strain SS2/1 which was previously
found in the colonic microbiota of three healthy adult humans
and was classiﬁed as a Clostridium indolis-like member of
Clostridium cluster XIVa.39 Although this unknown species has
Figure 3 Boxplots of the number of (A) F. prausnitzii (B) R. gnavus and (C) B. adolescentis in log10 per g of faeces per group. CD, Crohn’s disease.
Table 3 Median intensity of band-classes that differed significantly
between unaffected relatives of patients with Crohn’s disease and
unrelated controls
Median intensity (IQR)
Band-
class Bacterial species
Unaffected
relatives n[84
Unrelated
controls n[55
Corrected
p value
8.55 R torques 1.83 (0.42e3.74) 0 (0e2.21) 0.02
11.35 Unspecified member
of the Escherichia
colieShigella group
0 (0e0) 0 (0e0.20) 0.01
16.89 C aerofaciens 0 (0e0) 0 (0e0.78) 0.004
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not been fully taxonomically characterised, its clear phyloge-
netic afﬁliation to butyrate producers of cluster XIV and its
lower occurrence in patients with CD can be considered analo-
gous to the observations for F prausnitzii. So far, however, the
lower prevalence of this unknown Clostridium species has not
been related to CD.
Another major ﬁnding in this study is that in unaffected
relatives asymptomatic differences in three other bacterial
species were also identiﬁed. Both an unspeciﬁed member of the
E colieShigella group and C aerofaciens were less prevalent in
relatives of patients with CD. Strains of C aerofaciens were
previously isolated from patients with colon cancer, ulcerative
colitis and CD.40 The lower prevalence of this species in unaf-
fected relatives compared with unrelated controls is a novel
ﬁnding.
Band-class 8.55, which was found more in relatives of patients
with CD, phylogenetically most closely resembled C nexile,
R torques and C comes. The latter two commensal species have
previously been linked to CD.16 41 A possible role for C comes in
the pathogenesis of CD has been suggested based on its inter-
action with the immune system.42 C comes can activate
complement and thereby induce inﬂammation. Moreover, these
bacteria are not ingested by neutrophils and can bind immu-
noglobulins through their Fc region which prevents phagocy-
tosis of this microorganism.42 For R. torques no role in CD
pathophysiology has been suggested so far. Like R gnavus, R
torques belongs to Clostridium cluster XIVa, but, in contrast to the
other members of this group, R gnavus and R torques are
non-butyrate-producing members.43 Moreover, like R gnavus and
Candida albicans, R torques is known to degrade gastrointestinal
mucin.43 44 For C albicans, the capacity to break down mucus
and penetrate the mucin barrier also plays a role in its viru-
lence.44 Degradation of the mucosal barrier might thus enhance
bacterial translocation and lead to increased permeability of the
gut. C albicans was more frequently isolated from stool samples
from patients with CD (44%) and their unaffected relatives
(38%) compared with controls (22%) in a cohort comprising
similar French families and the same subjects used for the
present study.45 As R torques was also more frequently found in
relatives of patients with CD, an enhanced mucin degradation
capacity of the intestinal microbiota might precede or predispose
further to CD.
The intestinal microbiota of patients with CD has been
studied with different molecular techniques. Several ﬁndings had
previously been reported in various publications, but so far these
were only partial and/or not very persuasive. In this study
DGGE was used as a molecular technique to explore predomi-
nant differences in faecal samples of a large cohort of patients
with CD, their unaffected relatives and healthy controls. We
were able to describe in detail differences among the most
abundant members of the faecal microbiota and to conﬁrm and
integrate previous ﬁndings. In our opinion, large cohorts are
needed to study complex communities and, despite being labo-
rious, DGGE is a robust technique and highly valuable as an
exploratory tool.
The recruitment of the patients with CD through a tertiary
referral centre resulted in a cohort of patients with complicated
CD. Moreover, the speciﬁc design of the study, using both
related controls at increased risk for CD (mainly from multiplex
families) and independent control subjects, precluded us from
also powering the study for potential effects of disease pheno-
type or treatment. Subanalyses only revealed that patients with
CD might have even less faecal F prausnitzii after ileocolonic
resection compared with those that were never operated on.
As the group of patients in which we could evaluate this was
very small, whether this is a true ﬁnding should be studied
further. Despite the potential bias using this selected cohort
focusing on multiplex families, the CD-associated predominant
dysbiosis we found is in agreement with previous ﬁndings.
In conclusion, we provide for the ﬁrst time a set of ﬁve
bacterial species that characterise the predominant dysbiosis in
CD. We identiﬁed a faecal microbiota dysbiosis signature asso-
ciated with CD, characterised by a decreased presence of
F prausnitzii, B adolescentis, D invisus and an unknown species of
Clostridium cluster XIVa, and an increased presence of R gnavus.
The disproportions of three of these predominant species were
also quantitatively conﬁrmed, and the identiﬁcation suggests
lack of butyrate-producing capacity in conjunction with mucin
degradation as plausible physiopathological explanations.
Furthermore, the novelty in the experimental approach is that
not only were the predominant microbiota of patients with CD
and healthy controls studied, but for the ﬁrst time comparisons
with a large cohort of unaffected relatives of patients with CD
were also included. In contrast to CD-associated dysbiosis, the
dysbiosis in relatives of patients was not characterised by a lack
of butyrate-producing capacity, but similar enhanced mucin
degradation could be hypothesised. As the mucosal barrier is the
ﬁrst-line defence of the host against intestinal bacteria, the shift
from normobiosis to the dysbiosis observed in relatives of
patients with CD might be an intermediate step towards CD
and disease-associated dysbiosis. Despite the fact that we did
not study the overall butyrate-producing or mucin degradation
capacity of the microbiota in this cohort, it is intriguing to ﬁnd
a functional overlap between dysbalanced bacteria in patients
with CD and their unaffected relatives at risk. Further investi-
gation should reveal not only if the balance between butyrate
production and mucin degradation is indeed essential in predis-
posing to CD but also how this balance can be inﬂuenced.
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